Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant FOLFOX Chemoradiotherapy After Gastrectomy (Dose-Escalation)
ChiCTR-TNC-09000310Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2009
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oxaliplatin in gastric cancer (GC) (4 cohorts), sponsored by West China Hospital of Sichuan University. Primary endpoint: MTD. Started Jan 2009; status: completed.
02
Drugs
oxaliplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR-TNC-09000310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-09000310.